nodes	percent_of_prediction	percent_of_DWPC	metapath
Candesartan—PTGS1—kidney cancer	0.298	0.673	CbGaD
Candesartan—ABCB1—kidney cancer	0.145	0.327	CbGaD
Candesartan—ABCB1—Temsirolimus—kidney cancer	0.0434	0.126	CbGbCtD
Candesartan—CYP2C8—Pazopanib—kidney cancer	0.0337	0.0975	CbGbCtD
Candesartan—CYP2C9—Capecitabine—kidney cancer	0.0245	0.071	CbGbCtD
Candesartan—CYP2C8—Erlotinib—kidney cancer	0.0241	0.0696	CbGbCtD
Candesartan—ABCB1—Pazopanib—kidney cancer	0.0228	0.066	CbGbCtD
Candesartan—CYP2C8—Paclitaxel—kidney cancer	0.022	0.0637	CbGbCtD
Candesartan—ABCB1—Dactinomycin—kidney cancer	0.0209	0.0604	CbGbCtD
Candesartan—CYP2C8—Sorafenib—kidney cancer	0.0196	0.0566	CbGbCtD
Candesartan—ABCB1—Gemcitabine—kidney cancer	0.0165	0.0477	CbGbCtD
Candesartan—ABCB1—Erlotinib—kidney cancer	0.0163	0.0471	CbGbCtD
Candesartan—CYP2C9—Paclitaxel—kidney cancer	0.0154	0.0444	CbGbCtD
Candesartan—ABCB1—Paclitaxel—kidney cancer	0.0149	0.0431	CbGbCtD
Candesartan—CYP2C9—Sorafenib—kidney cancer	0.0136	0.0395	CbGbCtD
Candesartan—ABCB1—Sorafenib—kidney cancer	0.0132	0.0383	CbGbCtD
Candesartan—ABCB1—Vinblastine—kidney cancer	0.0131	0.0378	CbGbCtD
Candesartan—ABCB1—Vincristine—kidney cancer	0.0129	0.0372	CbGbCtD
Candesartan—ABCB1—Sunitinib—kidney cancer	0.0107	0.031	CbGbCtD
Candesartan—ABCB1—Doxorubicin—kidney cancer	0.00803	0.0232	CbGbCtD
Candesartan—AGTR1—nephron—kidney cancer	0.00533	0.327	CbGeAlD
Candesartan—CYP2C9—urine—kidney cancer	0.00206	0.126	CbGeAlD
Candesartan—Irbesartan—JUN—kidney cancer	0.00163	0.644	CrCbGaD
Candesartan—AGTR1—nephron tubule—kidney cancer	0.00115	0.0707	CbGeAlD
Candesartan—AGTR1—renal system—kidney cancer	0.00105	0.0642	CbGeAlD
Candesartan—AGTR1—kidney—kidney cancer	0.00101	0.0621	CbGeAlD
Candesartan—AGTR1—cortex of kidney—kidney cancer	0.000984	0.0605	CbGeAlD
Candesartan—AGTR1—cardiac atrium—kidney cancer	0.000936	0.0575	CbGeAlD
Candesartan—CYP2C8—renal system—kidney cancer	0.000567	0.0348	CbGeAlD
Candesartan—CYP2C8—kidney—kidney cancer	0.000548	0.0337	CbGeAlD
Candesartan—Irbesartan—PTGS1—kidney cancer	0.000471	0.186	CrCbGaD
Candesartan—PTGS1—renal system—kidney cancer	0.00046	0.0282	CbGeAlD
Candesartan—PTGS1—kidney—kidney cancer	0.000444	0.0273	CbGeAlD
Candesartan—PTGS1—cardiac atrium—kidney cancer	0.000412	0.0253	CbGeAlD
Candesartan—ABCB1—nephron tubule—kidney cancer	0.000299	0.0184	CbGeAlD
Candesartan—Telmisartan—ABCB1—kidney cancer	0.000284	0.112	CrCbGaD
Candesartan—ABCB1—renal system—kidney cancer	0.000272	0.0167	CbGeAlD
Candesartan—ABCB1—kidney—kidney cancer	0.000263	0.0161	CbGeAlD
Candesartan—ABCB1—cortex of kidney—kidney cancer	0.000256	0.0157	CbGeAlD
Candesartan—ABCB1—gonad—kidney cancer	0.000244	0.015	CbGeAlD
Candesartan—Gastrointestinal disorder—Sunitinib—kidney cancer	0.000172	0.00105	CcSEcCtD
Candesartan—Musculoskeletal discomfort—Dactinomycin—kidney cancer	0.000172	0.00105	CcSEcCtD
Candesartan—Asthenia—Vinblastine—kidney cancer	0.000172	0.00105	CcSEcCtD
Candesartan—Fatigue—Sunitinib—kidney cancer	0.000172	0.00105	CcSEcCtD
Candesartan—Asthenia—Everolimus—kidney cancer	0.000171	0.00104	CcSEcCtD
Candesartan—Cough—Gemcitabine—kidney cancer	0.000171	0.00104	CcSEcCtD
Candesartan—Acute coronary syndrome—Capecitabine—kidney cancer	0.00017	0.00104	CcSEcCtD
Candesartan—Gastrointestinal pain—Sorafenib—kidney cancer	0.000169	0.00103	CcSEcCtD
Candesartan—Renal failure—Capecitabine—kidney cancer	0.000169	0.00103	CcSEcCtD
Candesartan—Hypertension—Gemcitabine—kidney cancer	0.000169	0.00103	CcSEcCtD
Candesartan—Myocardial infarction—Capecitabine—kidney cancer	0.000169	0.00103	CcSEcCtD
Candesartan—Pruritus—Everolimus—kidney cancer	0.000169	0.00103	CcSEcCtD
Candesartan—Arthralgia—Gemcitabine—kidney cancer	0.000167	0.00102	CcSEcCtD
Candesartan—Chest pain—Gemcitabine—kidney cancer	0.000167	0.00102	CcSEcCtD
Candesartan—Myalgia—Gemcitabine—kidney cancer	0.000167	0.00102	CcSEcCtD
Candesartan—Asthenia—Erlotinib—kidney cancer	0.000165	0.00101	CcSEcCtD
Candesartan—Mental disorder—Paclitaxel—kidney cancer	0.000165	0.00101	CcSEcCtD
Candesartan—Thrombocytopenia—Vincristine—kidney cancer	0.000165	0.00101	CcSEcCtD
Candesartan—Urticaria—Sorafenib—kidney cancer	0.000164	0.001	CcSEcCtD
Candesartan—Haematuria—Capecitabine—kidney cancer	0.000164	0.001	CcSEcCtD
Candesartan—Malnutrition—Paclitaxel—kidney cancer	0.000164	0.001	CcSEcCtD
Candesartan—Diarrhoea—Vinblastine—kidney cancer	0.000164	0.000999	CcSEcCtD
Candesartan—Abdominal pain—Sorafenib—kidney cancer	0.000163	0.000998	CcSEcCtD
Candesartan—Body temperature increased—Sorafenib—kidney cancer	0.000163	0.000998	CcSEcCtD
Candesartan—Diarrhoea—Everolimus—kidney cancer	0.000163	0.000995	CcSEcCtD
Candesartan—Gastrointestinal pain—Sunitinib—kidney cancer	0.000163	0.000994	CcSEcCtD
Candesartan—Hyperhidrosis—Vincristine—kidney cancer	0.000163	0.000993	CcSEcCtD
Candesartan—Pruritus—Erlotinib—kidney cancer	0.000163	0.000993	CcSEcCtD
Candesartan—Fatigue—Dactinomycin—kidney cancer	0.000162	0.000992	CcSEcCtD
Candesartan—Epistaxis—Capecitabine—kidney cancer	0.000162	0.000991	CcSEcCtD
Candesartan—Agranulocytosis—Capecitabine—kidney cancer	0.000161	0.00098	CcSEcCtD
Candesartan—Cardiac failure congestive—Doxorubicin—kidney cancer	0.000159	0.000969	CcSEcCtD
Candesartan—Back pain—Paclitaxel—kidney cancer	0.000158	0.000967	CcSEcCtD
Candesartan—Dizziness—Vinblastine—kidney cancer	0.000158	0.000966	CcSEcCtD
Candesartan—Dizziness—Everolimus—kidney cancer	0.000158	0.000962	CcSEcCtD
Candesartan—Abdominal pain—Sunitinib—kidney cancer	0.000157	0.00096	CcSEcCtD
Candesartan—Body temperature increased—Sunitinib—kidney cancer	0.000157	0.00096	CcSEcCtD
Candesartan—Diarrhoea—Erlotinib—kidney cancer	0.000157	0.00096	CcSEcCtD
Candesartan—Hypotension—Vincristine—kidney cancer	0.000157	0.00096	CcSEcCtD
Candesartan—Thrombocytopenia—Gemcitabine—kidney cancer	0.000156	0.000955	CcSEcCtD
Candesartan—Haemoglobin—Capecitabine—kidney cancer	0.000155	0.000948	CcSEcCtD
Candesartan—Rhinitis—Capecitabine—kidney cancer	0.000155	0.000945	CcSEcCtD
Candesartan—Haemorrhage—Capecitabine—kidney cancer	0.000154	0.000943	CcSEcCtD
Candesartan—Hepatitis—Capecitabine—kidney cancer	0.000154	0.000943	CcSEcCtD
Candesartan—Hyperhidrosis—Gemcitabine—kidney cancer	0.000154	0.000942	CcSEcCtD
Candesartan—Gastrointestinal pain—Dactinomycin—kidney cancer	0.000154	0.000941	CcSEcCtD
Candesartan—Musculoskeletal discomfort—Vincristine—kidney cancer	0.000153	0.000936	CcSEcCtD
Candesartan—Pharyngitis—Capecitabine—kidney cancer	0.000153	0.000936	CcSEcCtD
Candesartan—Urinary tract disorder—Capecitabine—kidney cancer	0.000152	0.000931	CcSEcCtD
Candesartan—Oedema peripheral—Capecitabine—kidney cancer	0.000152	0.000929	CcSEcCtD
Candesartan—Vomiting—Vinblastine—kidney cancer	0.000152	0.000928	CcSEcCtD
Candesartan—Dizziness—Erlotinib—kidney cancer	0.000152	0.000928	CcSEcCtD
Candesartan—Vomiting—Everolimus—kidney cancer	0.000151	0.000925	CcSEcCtD
Candesartan—Anaemia—Paclitaxel—kidney cancer	0.000151	0.000924	CcSEcCtD
Candesartan—Urethral disorder—Capecitabine—kidney cancer	0.000151	0.000924	CcSEcCtD
Candesartan—Renal impairment—Doxorubicin—kidney cancer	0.000151	0.000923	CcSEcCtD
Candesartan—Paraesthesia—Vincristine—kidney cancer	0.000151	0.000923	CcSEcCtD
Candesartan—Rash—Everolimus—kidney cancer	0.00015	0.000917	CcSEcCtD
Candesartan—Dermatitis—Everolimus—kidney cancer	0.00015	0.000916	CcSEcCtD
Candesartan—Headache—Vinblastine—kidney cancer	0.00015	0.000915	CcSEcCtD
Candesartan—Angioedema—Paclitaxel—kidney cancer	0.00015	0.000914	CcSEcCtD
Candesartan—Headache—Everolimus—kidney cancer	0.000149	0.000911	CcSEcCtD
Candesartan—Hypotension—Gemcitabine—kidney cancer	0.000149	0.000911	CcSEcCtD
Candesartan—Abdominal pain—Dactinomycin—kidney cancer	0.000149	0.000909	CcSEcCtD
Candesartan—Body temperature increased—Dactinomycin—kidney cancer	0.000149	0.000909	CcSEcCtD
Candesartan—Asthenia—Sorafenib—kidney cancer	0.000148	0.000906	CcSEcCtD
Candesartan—Losartan—ABCB1—kidney cancer	0.000148	0.0582	CrCbGaD
Candesartan—Cardiac failure—Doxorubicin—kidney cancer	0.000147	0.0009	CcSEcCtD
Candesartan—Vertigo—Paclitaxel—kidney cancer	0.000147	0.000899	CcSEcCtD
Candesartan—Leukopenia—Paclitaxel—kidney cancer	0.000147	0.000895	CcSEcCtD
Candesartan—Pruritus—Sorafenib—kidney cancer	0.000146	0.000893	CcSEcCtD
Candesartan—Vomiting—Erlotinib—kidney cancer	0.000146	0.000892	CcSEcCtD
Candesartan—Musculoskeletal discomfort—Gemcitabine—kidney cancer	0.000145	0.000888	CcSEcCtD
Candesartan—Gastrointestinal disorder—Vincristine—kidney cancer	0.000145	0.000887	CcSEcCtD
Candesartan—Fatigue—Vincristine—kidney cancer	0.000145	0.000886	CcSEcCtD
Candesartan—Rash—Erlotinib—kidney cancer	0.000145	0.000885	CcSEcCtD
Candesartan—Dermatitis—Erlotinib—kidney cancer	0.000145	0.000884	CcSEcCtD
Candesartan—Palpitations—Paclitaxel—kidney cancer	0.000145	0.000884	CcSEcCtD
Candesartan—Hyponatraemia—Doxorubicin—kidney cancer	0.000144	0.000882	CcSEcCtD
Candesartan—Headache—Erlotinib—kidney cancer	0.000144	0.000879	CcSEcCtD
Candesartan—Paraesthesia—Gemcitabine—kidney cancer	0.000143	0.000875	CcSEcCtD
Candesartan—Cough—Paclitaxel—kidney cancer	0.000143	0.000873	CcSEcCtD
Candesartan—Asthenia—Sunitinib—kidney cancer	0.000143	0.000872	CcSEcCtD
Candesartan—Dyspnoea—Gemcitabine—kidney cancer	0.000142	0.000869	CcSEcCtD
Candesartan—Nausea—Vinblastine—kidney cancer	0.000142	0.000867	CcSEcCtD
Candesartan—Somnolence—Gemcitabine—kidney cancer	0.000142	0.000867	CcSEcCtD
Candesartan—Nausea—Everolimus—kidney cancer	0.000142	0.000864	CcSEcCtD
Candesartan—Diarrhoea—Sorafenib—kidney cancer	0.000141	0.000864	CcSEcCtD
Candesartan—Hypertension—Paclitaxel—kidney cancer	0.000141	0.000863	CcSEcCtD
Candesartan—Pruritus—Sunitinib—kidney cancer	0.000141	0.00086	CcSEcCtD
Candesartan—Chest pain—Paclitaxel—kidney cancer	0.000139	0.000851	CcSEcCtD
Candesartan—Arthralgia—Paclitaxel—kidney cancer	0.000139	0.000851	CcSEcCtD
Candesartan—Myalgia—Paclitaxel—kidney cancer	0.000139	0.000851	CcSEcCtD
Candesartan—Anxiety—Paclitaxel—kidney cancer	0.000139	0.000849	CcSEcCtD
Candesartan—Gastrointestinal disorder—Gemcitabine—kidney cancer	0.000138	0.000842	CcSEcCtD
Candesartan—Fatigue—Gemcitabine—kidney cancer	0.000138	0.000841	CcSEcCtD
Candesartan—Gastrointestinal pain—Vincristine—kidney cancer	0.000138	0.00084	CcSEcCtD
Candesartan—Dizziness—Sorafenib—kidney cancer	0.000137	0.000835	CcSEcCtD
Candesartan—Nausea—Erlotinib—kidney cancer	0.000137	0.000834	CcSEcCtD
Candesartan—Diarrhoea—Sunitinib—kidney cancer	0.000136	0.000831	CcSEcCtD
Candesartan—Mental disorder—Capecitabine—kidney cancer	0.000135	0.000826	CcSEcCtD
Candesartan—Asthenia—Dactinomycin—kidney cancer	0.000135	0.000825	CcSEcCtD
Candesartan—Blood creatinine increased—Doxorubicin—kidney cancer	0.000135	0.000823	CcSEcCtD
Candesartan—Malnutrition—Capecitabine—kidney cancer	0.000134	0.000821	CcSEcCtD
Candesartan—Abdominal pain—Vincristine—kidney cancer	0.000133	0.000812	CcSEcCtD
Candesartan—Body temperature increased—Vincristine—kidney cancer	0.000133	0.000812	CcSEcCtD
Candesartan—Dizziness—Sunitinib—kidney cancer	0.000132	0.000803	CcSEcCtD
Candesartan—Vomiting—Sorafenib—kidney cancer	0.000131	0.000803	CcSEcCtD
Candesartan—Thrombocytopenia—Paclitaxel—kidney cancer	0.000131	0.000799	CcSEcCtD
Candesartan—Tachycardia—Paclitaxel—kidney cancer	0.00013	0.000797	CcSEcCtD
Candesartan—Rash—Sorafenib—kidney cancer	0.00013	0.000796	CcSEcCtD
Candesartan—Dermatitis—Sorafenib—kidney cancer	0.00013	0.000795	CcSEcCtD
Candesartan—Back pain—Capecitabine—kidney cancer	0.00013	0.000794	CcSEcCtD
Candesartan—Headache—Sorafenib—kidney cancer	0.00013	0.000791	CcSEcCtD
Candesartan—Hyperhidrosis—Paclitaxel—kidney cancer	0.000129	0.000789	CcSEcCtD
Candesartan—Diarrhoea—Dactinomycin—kidney cancer	0.000129	0.000787	CcSEcCtD
Candesartan—Vomiting—Sunitinib—kidney cancer	0.000127	0.000773	CcSEcCtD
Candesartan—Body temperature increased—Gemcitabine—kidney cancer	0.000126	0.000771	CcSEcCtD
Candesartan—Rash—Sunitinib—kidney cancer	0.000125	0.000766	CcSEcCtD
Candesartan—Dermatitis—Sunitinib—kidney cancer	0.000125	0.000765	CcSEcCtD
Candesartan—Hypotension—Paclitaxel—kidney cancer	0.000125	0.000763	CcSEcCtD
Candesartan—Headache—Sunitinib—kidney cancer	0.000125	0.000761	CcSEcCtD
Candesartan—Anaemia—Capecitabine—kidney cancer	0.000124	0.000759	CcSEcCtD
Candesartan—Nausea—Sorafenib—kidney cancer	0.000123	0.00075	CcSEcCtD
Candesartan—Musculoskeletal discomfort—Paclitaxel—kidney cancer	0.000122	0.000744	CcSEcCtD
Candesartan—Angina pectoris—Doxorubicin—kidney cancer	0.000121	0.00074	CcSEcCtD
Candesartan—Vertigo—Capecitabine—kidney cancer	0.000121	0.000737	CcSEcCtD
Candesartan—Asthenia—Vincristine—kidney cancer	0.000121	0.000737	CcSEcCtD
Candesartan—Leukopenia—Capecitabine—kidney cancer	0.00012	0.000735	CcSEcCtD
Candesartan—Paraesthesia—Paclitaxel—kidney cancer	0.00012	0.000733	CcSEcCtD
Candesartan—Vomiting—Dactinomycin—kidney cancer	0.00012	0.000731	CcSEcCtD
Candesartan—Bronchitis—Doxorubicin—kidney cancer	0.00012	0.00073	CcSEcCtD
Candesartan—Dyspnoea—Paclitaxel—kidney cancer	0.000119	0.000728	CcSEcCtD
Candesartan—Somnolence—Paclitaxel—kidney cancer	0.000119	0.000726	CcSEcCtD
Candesartan—Palpitations—Capecitabine—kidney cancer	0.000119	0.000725	CcSEcCtD
Candesartan—Rash—Dactinomycin—kidney cancer	0.000119	0.000725	CcSEcCtD
Candesartan—Nausea—Sunitinib—kidney cancer	0.000118	0.000722	CcSEcCtD
Candesartan—Dyspepsia—Paclitaxel—kidney cancer	0.000118	0.000718	CcSEcCtD
Candesartan—Cough—Capecitabine—kidney cancer	0.000117	0.000716	CcSEcCtD
Candesartan—Neutropenia—Doxorubicin—kidney cancer	0.000116	0.00071	CcSEcCtD
Candesartan—Hypertension—Capecitabine—kidney cancer	0.000116	0.000709	CcSEcCtD
Candesartan—Upper respiratory tract infection—Doxorubicin—kidney cancer	0.000116	0.000706	CcSEcCtD
Candesartan—Gastrointestinal disorder—Paclitaxel—kidney cancer	0.000115	0.000705	CcSEcCtD
Candesartan—Fatigue—Paclitaxel—kidney cancer	0.000115	0.000704	CcSEcCtD
Candesartan—Diarrhoea—Vincristine—kidney cancer	0.000115	0.000703	CcSEcCtD
Candesartan—Asthenia—Gemcitabine—kidney cancer	0.000115	0.000699	CcSEcCtD
Candesartan—Myalgia—Capecitabine—kidney cancer	0.000114	0.000699	CcSEcCtD
Candesartan—Arthralgia—Capecitabine—kidney cancer	0.000114	0.000699	CcSEcCtD
Candesartan—Chest pain—Capecitabine—kidney cancer	0.000114	0.000699	CcSEcCtD
Candesartan—Anxiety—Capecitabine—kidney cancer	0.000114	0.000696	CcSEcCtD
Candesartan—Pruritus—Gemcitabine—kidney cancer	0.000113	0.00069	CcSEcCtD
Candesartan—Hyperglycaemia—Doxorubicin—kidney cancer	0.000112	0.000685	CcSEcCtD
Candesartan—Nausea—Dactinomycin—kidney cancer	0.000112	0.000683	CcSEcCtD
Candesartan—Dizziness—Vincristine—kidney cancer	0.000111	0.00068	CcSEcCtD
Candesartan—Gastrointestinal pain—Paclitaxel—kidney cancer	0.000109	0.000667	CcSEcCtD
Candesartan—Diarrhoea—Gemcitabine—kidney cancer	0.000109	0.000667	CcSEcCtD
Candesartan—Renal failure—Doxorubicin—kidney cancer	0.000109	0.000665	CcSEcCtD
Candesartan—Thrombocytopenia—Capecitabine—kidney cancer	0.000107	0.000656	CcSEcCtD
Candesartan—Tachycardia—Capecitabine—kidney cancer	0.000107	0.000654	CcSEcCtD
Candesartan—Vomiting—Vincristine—kidney cancer	0.000107	0.000653	CcSEcCtD
Candesartan—Urticaria—Paclitaxel—kidney cancer	0.000106	0.000648	CcSEcCtD
Candesartan—Rash—Vincristine—kidney cancer	0.000106	0.000648	CcSEcCtD
Candesartan—Hyperhidrosis—Capecitabine—kidney cancer	0.000106	0.000648	CcSEcCtD
Candesartan—Dermatitis—Vincristine—kidney cancer	0.000106	0.000647	CcSEcCtD
Candesartan—Haematuria—Doxorubicin—kidney cancer	0.000106	0.000645	CcSEcCtD
Candesartan—Body temperature increased—Paclitaxel—kidney cancer	0.000106	0.000645	CcSEcCtD
Candesartan—Abdominal pain—Paclitaxel—kidney cancer	0.000106	0.000645	CcSEcCtD
Candesartan—Headache—Vincristine—kidney cancer	0.000105	0.000644	CcSEcCtD
Candesartan—Epistaxis—Doxorubicin—kidney cancer	0.000105	0.000639	CcSEcCtD
Candesartan—Sinusitis—Doxorubicin—kidney cancer	0.000104	0.000635	CcSEcCtD
Candesartan—Agranulocytosis—Doxorubicin—kidney cancer	0.000103	0.000632	CcSEcCtD
Candesartan—Hypotension—Capecitabine—kidney cancer	0.000103	0.000626	CcSEcCtD
Candesartan—Vomiting—Gemcitabine—kidney cancer	0.000102	0.00062	CcSEcCtD
Candesartan—Rash—Gemcitabine—kidney cancer	0.000101	0.000615	CcSEcCtD
Candesartan—Dermatitis—Gemcitabine—kidney cancer	0.000101	0.000614	CcSEcCtD
Candesartan—Haemoglobin—Doxorubicin—kidney cancer	0.0001	0.000611	CcSEcCtD
Candesartan—Headache—Gemcitabine—kidney cancer	0.0001	0.000611	CcSEcCtD
Candesartan—Nausea—Vincristine—kidney cancer	0.0001	0.00061	CcSEcCtD
Candesartan—Musculoskeletal discomfort—Capecitabine—kidney cancer	9.99e-05	0.00061	CcSEcCtD
Candesartan—Rhinitis—Doxorubicin—kidney cancer	9.98e-05	0.000609	CcSEcCtD
Candesartan—Haemorrhage—Doxorubicin—kidney cancer	9.95e-05	0.000608	CcSEcCtD
Candesartan—Hepatitis—Doxorubicin—kidney cancer	9.95e-05	0.000608	CcSEcCtD
Candesartan—Pharyngitis—Doxorubicin—kidney cancer	9.88e-05	0.000603	CcSEcCtD
Candesartan—Paraesthesia—Capecitabine—kidney cancer	9.85e-05	0.000601	CcSEcCtD
Candesartan—Urinary tract disorder—Doxorubicin—kidney cancer	9.83e-05	0.0006	CcSEcCtD
Candesartan—Oedema peripheral—Doxorubicin—kidney cancer	9.81e-05	0.000599	CcSEcCtD
Candesartan—Dyspnoea—Capecitabine—kidney cancer	9.78e-05	0.000597	CcSEcCtD
Candesartan—Urethral disorder—Doxorubicin—kidney cancer	9.76e-05	0.000596	CcSEcCtD
Candesartan—Dyspepsia—Capecitabine—kidney cancer	9.66e-05	0.00059	CcSEcCtD
Candesartan—Asthenia—Paclitaxel—kidney cancer	9.59e-05	0.000586	CcSEcCtD
Candesartan—Nausea—Gemcitabine—kidney cancer	9.48e-05	0.000579	CcSEcCtD
Candesartan—Gastrointestinal disorder—Capecitabine—kidney cancer	9.47e-05	0.000578	CcSEcCtD
Candesartan—Fatigue—Capecitabine—kidney cancer	9.46e-05	0.000578	CcSEcCtD
Candesartan—Pruritus—Paclitaxel—kidney cancer	9.46e-05	0.000577	CcSEcCtD
Candesartan—Diarrhoea—Paclitaxel—kidney cancer	9.15e-05	0.000558	CcSEcCtD
Candesartan—Gastrointestinal pain—Capecitabine—kidney cancer	8.97e-05	0.000548	CcSEcCtD
Candesartan—Dizziness—Paclitaxel—kidney cancer	8.84e-05	0.00054	CcSEcCtD
Candesartan—Mental disorder—Doxorubicin—kidney cancer	8.72e-05	0.000532	CcSEcCtD
Candesartan—Urticaria—Capecitabine—kidney cancer	8.71e-05	0.000532	CcSEcCtD
Candesartan—Abdominal pain—Capecitabine—kidney cancer	8.67e-05	0.00053	CcSEcCtD
Candesartan—Body temperature increased—Capecitabine—kidney cancer	8.67e-05	0.00053	CcSEcCtD
Candesartan—Malnutrition—Doxorubicin—kidney cancer	8.66e-05	0.000529	CcSEcCtD
Candesartan—Vomiting—Paclitaxel—kidney cancer	8.5e-05	0.000519	CcSEcCtD
Candesartan—Rash—Paclitaxel—kidney cancer	8.43e-05	0.000515	CcSEcCtD
Candesartan—Dermatitis—Paclitaxel—kidney cancer	8.42e-05	0.000514	CcSEcCtD
Candesartan—Back pain—Doxorubicin—kidney cancer	8.38e-05	0.000512	CcSEcCtD
Candesartan—Headache—Paclitaxel—kidney cancer	8.37e-05	0.000511	CcSEcCtD
Candesartan—Anaemia—Doxorubicin—kidney cancer	8.01e-05	0.000489	CcSEcCtD
Candesartan—Nausea—Paclitaxel—kidney cancer	7.94e-05	0.000485	CcSEcCtD
Candesartan—Asthenia—Capecitabine—kidney cancer	7.87e-05	0.000481	CcSEcCtD
Candesartan—Vertigo—Doxorubicin—kidney cancer	7.78e-05	0.000475	CcSEcCtD
Candesartan—Pruritus—Capecitabine—kidney cancer	7.76e-05	0.000474	CcSEcCtD
Candesartan—Leukopenia—Doxorubicin—kidney cancer	7.76e-05	0.000474	CcSEcCtD
Candesartan—Palpitations—Doxorubicin—kidney cancer	7.66e-05	0.000468	CcSEcCtD
Candesartan—Cough—Doxorubicin—kidney cancer	7.56e-05	0.000462	CcSEcCtD
Candesartan—Diarrhoea—Capecitabine—kidney cancer	7.51e-05	0.000458	CcSEcCtD
Candesartan—Hypertension—Doxorubicin—kidney cancer	7.48e-05	0.000457	CcSEcCtD
Candesartan—Arthralgia—Doxorubicin—kidney cancer	7.38e-05	0.00045	CcSEcCtD
Candesartan—Chest pain—Doxorubicin—kidney cancer	7.38e-05	0.00045	CcSEcCtD
Candesartan—Myalgia—Doxorubicin—kidney cancer	7.38e-05	0.00045	CcSEcCtD
Candesartan—Anxiety—Doxorubicin—kidney cancer	7.35e-05	0.000449	CcSEcCtD
Candesartan—Dizziness—Capecitabine—kidney cancer	7.25e-05	0.000443	CcSEcCtD
Candesartan—Vomiting—Capecitabine—kidney cancer	6.98e-05	0.000426	CcSEcCtD
Candesartan—Thrombocytopenia—Doxorubicin—kidney cancer	6.92e-05	0.000423	CcSEcCtD
Candesartan—Rash—Capecitabine—kidney cancer	6.92e-05	0.000422	CcSEcCtD
Candesartan—Dermatitis—Capecitabine—kidney cancer	6.91e-05	0.000422	CcSEcCtD
Candesartan—Tachycardia—Doxorubicin—kidney cancer	6.9e-05	0.000421	CcSEcCtD
Candesartan—Headache—Capecitabine—kidney cancer	6.87e-05	0.00042	CcSEcCtD
Candesartan—Hyperhidrosis—Doxorubicin—kidney cancer	6.84e-05	0.000417	CcSEcCtD
Candesartan—Hypotension—Doxorubicin—kidney cancer	6.61e-05	0.000403	CcSEcCtD
Candesartan—Nausea—Capecitabine—kidney cancer	6.52e-05	0.000398	CcSEcCtD
Candesartan—Musculoskeletal discomfort—Doxorubicin—kidney cancer	6.44e-05	0.000393	CcSEcCtD
Candesartan—Paraesthesia—Doxorubicin—kidney cancer	6.35e-05	0.000388	CcSEcCtD
Candesartan—Dyspnoea—Doxorubicin—kidney cancer	6.3e-05	0.000385	CcSEcCtD
Candesartan—Somnolence—Doxorubicin—kidney cancer	6.29e-05	0.000384	CcSEcCtD
Candesartan—Dyspepsia—Doxorubicin—kidney cancer	6.22e-05	0.00038	CcSEcCtD
Candesartan—Gastrointestinal disorder—Doxorubicin—kidney cancer	6.11e-05	0.000373	CcSEcCtD
Candesartan—Fatigue—Doxorubicin—kidney cancer	6.1e-05	0.000372	CcSEcCtD
Candesartan—Gastrointestinal pain—Doxorubicin—kidney cancer	5.78e-05	0.000353	CcSEcCtD
Candesartan—Urticaria—Doxorubicin—kidney cancer	5.62e-05	0.000343	CcSEcCtD
Candesartan—Body temperature increased—Doxorubicin—kidney cancer	5.59e-05	0.000341	CcSEcCtD
Candesartan—Abdominal pain—Doxorubicin—kidney cancer	5.59e-05	0.000341	CcSEcCtD
Candesartan—Asthenia—Doxorubicin—kidney cancer	5.07e-05	0.00031	CcSEcCtD
Candesartan—Pruritus—Doxorubicin—kidney cancer	5e-05	0.000305	CcSEcCtD
Candesartan—Diarrhoea—Doxorubicin—kidney cancer	4.84e-05	0.000295	CcSEcCtD
Candesartan—Dizziness—Doxorubicin—kidney cancer	4.68e-05	0.000286	CcSEcCtD
Candesartan—Vomiting—Doxorubicin—kidney cancer	4.5e-05	0.000275	CcSEcCtD
Candesartan—Rash—Doxorubicin—kidney cancer	4.46e-05	0.000272	CcSEcCtD
Candesartan—Dermatitis—Doxorubicin—kidney cancer	4.45e-05	0.000272	CcSEcCtD
Candesartan—Headache—Doxorubicin—kidney cancer	4.43e-05	0.00027	CcSEcCtD
Candesartan—Nausea—Doxorubicin—kidney cancer	4.2e-05	0.000256	CcSEcCtD
Candesartan—CYP2C8—Metabolism—ACY1—kidney cancer	2.86e-05	0.000974	CbGpPWpGaD
Candesartan—ABCB1—HIF-1-alpha transcription factor network—VEGFA—kidney cancer	2.86e-05	0.000973	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—APRT—kidney cancer	2.85e-05	0.000972	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—FH—kidney cancer	2.85e-05	0.000972	CbGpPWpGaD
Candesartan—ABCB1—Transmembrane transport of small molecules—ATP7B—kidney cancer	2.79e-05	0.000952	CbGpPWpGaD
Candesartan—ABCB1—Transmembrane transport of small molecules—ANXA2—kidney cancer	2.79e-05	0.000952	CbGpPWpGaD
Candesartan—ABCB1—Transmembrane transport of small molecules—SLC5A3—kidney cancer	2.79e-05	0.000952	CbGpPWpGaD
Candesartan—CYP2C9—Biological oxidations—GSTM1—kidney cancer	2.79e-05	0.000951	CbGpPWpGaD
Candesartan—PTGS1—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	2.79e-05	0.00095	CbGpPWpGaD
Candesartan—UGT1A3—Metabolism—ITPR2—kidney cancer	2.78e-05	0.000946	CbGpPWpGaD
Candesartan—CYP2C9—Metapathway biotransformation—GSTM1—kidney cancer	2.75e-05	0.000938	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—GRB7—kidney cancer	2.7e-05	0.000919	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—GPC3—kidney cancer	2.68e-05	0.000914	CbGpPWpGaD
Candesartan—CYP2C9—Biological oxidations—CYP1A1—kidney cancer	2.65e-05	0.000902	CbGpPWpGaD
Candesartan—CYP2C9—Metapathway biotransformation—CYP1A1—kidney cancer	2.61e-05	0.000889	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—CA2—kidney cancer	2.61e-05	0.000889	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—ALAD—kidney cancer	2.54e-05	0.000866	CbGpPWpGaD
Candesartan—UGT1A3—Metabolism—ACHE—kidney cancer	2.53e-05	0.000862	CbGpPWpGaD
Candesartan—UGT1A3—Metabolism—GSTT1—kidney cancer	2.53e-05	0.000862	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—ITPR2—kidney cancer	2.51e-05	0.000854	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—ACY1—kidney cancer	2.49e-05	0.000849	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—ST3GAL2—kidney cancer	2.48e-05	0.000846	CbGpPWpGaD
Candesartan—ABCB1—Allograft Rejection—VEGFA—kidney cancer	2.47e-05	0.000842	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism of lipids and lipoproteins—CRABP1—kidney cancer	2.44e-05	0.000831	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—PDHB—kidney cancer	2.43e-05	0.000829	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—ALDH1A1—kidney cancer	2.43e-05	0.000827	CbGpPWpGaD
Candesartan—CYP2C8—Biological oxidations—POMC—kidney cancer	2.42e-05	0.000826	CbGpPWpGaD
Candesartan—UGT1A3—Metabolism—SCARB1—kidney cancer	2.4e-05	0.000816	CbGpPWpGaD
Candesartan—UGT1A3—Metabolism—PTGS1—kidney cancer	2.37e-05	0.000808	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—ACY1—kidney cancer	2.33e-05	0.000793	CbGpPWpGaD
Candesartan—UGT1A3—Metabolism—PSMD7—kidney cancer	2.33e-05	0.000792	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—PGK1—kidney cancer	2.33e-05	0.000792	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—SLC5A3—kidney cancer	2.33e-05	0.000792	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—CCBL1—kidney cancer	2.29e-05	0.000779	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—LDHB—kidney cancer	2.28e-05	0.000777	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—CTNNA1—kidney cancer	2.27e-05	0.000774	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—HSPB1—kidney cancer	2.26e-05	0.00077	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—EIF4EBP1—kidney cancer	2.26e-05	0.00077	CbGpPWpGaD
Candesartan—UGT1A3—Metabolism—BCHE—kidney cancer	2.21e-05	0.000751	CbGpPWpGaD
Candesartan—UGT1A3—Metabolism—SLC5A5—kidney cancer	2.18e-05	0.000742	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—PDHB—kidney cancer	2.12e-05	0.000722	CbGpPWpGaD
Candesartan—UGT1A3—Metabolism—SLC2A1—kidney cancer	2.1e-05	0.000717	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—PSMD7—kidney cancer	2.1e-05	0.000716	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—TSC1—kidney cancer	2.1e-05	0.000716	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—ANXA1—kidney cancer	2.1e-05	0.000716	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism of lipids and lipoproteins—ACHE—kidney cancer	2.07e-05	0.000705	CbGpPWpGaD
Candesartan—ABCB1—Integrated Pancreatic Cancer Pathway—APC—kidney cancer	2.04e-05	0.000695	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—FLT1—kidney cancer	2.03e-05	0.000693	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—CCBL1—kidney cancer	1.99e-05	0.000679	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism of lipids and lipoproteins—CRABP1—kidney cancer	1.99e-05	0.000676	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—PPAT—kidney cancer	1.98e-05	0.000675	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—GLIPR1—kidney cancer	1.98e-05	0.000675	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—PDHB—kidney cancer	1.98e-05	0.000674	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—CA9—kidney cancer	1.98e-05	0.000674	CbGpPWpGaD
Candesartan—CYP2C9—Biological oxidations—POMC—kidney cancer	1.97e-05	0.000672	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism of lipids and lipoproteins—SCARB1—kidney cancer	1.96e-05	0.000667	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism of lipids and lipoproteins—PTGS1—kidney cancer	1.94e-05	0.00066	CbGpPWpGaD
Candesartan—PTGS1—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	1.93e-05	0.000659	CbGpPWpGaD
Candesartan—AGTR1—GPCR downstream signaling—POMC—kidney cancer	1.92e-05	0.000654	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—JUNB—kidney cancer	1.89e-05	0.000642	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—PAK1—kidney cancer	1.89e-05	0.000642	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—CCBL1—kidney cancer	1.86e-05	0.000634	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—APRT—kidney cancer	1.84e-05	0.000628	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—FH—kidney cancer	1.84e-05	0.000628	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	1.8e-05	0.000614	CbGpPWpGaD
Candesartan—UGT1A3—Metabolism—GSTP1—kidney cancer	1.75e-05	0.000598	CbGpPWpGaD
Candesartan—AGTR1—Signaling by GPCR—POMC—kidney cancer	1.74e-05	0.000594	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—GPC3—kidney cancer	1.73e-05	0.00059	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—PPAT—kidney cancer	1.73e-05	0.000588	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—GLIPR1—kidney cancer	1.73e-05	0.000588	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—CA2—kidney cancer	1.69e-05	0.000574	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism of lipids and lipoproteins—ACHE—kidney cancer	1.68e-05	0.000573	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—CRABP1—kidney cancer	1.68e-05	0.000573	CbGpPWpGaD
Candesartan—UGT1A3—Metabolism—ABCB1—kidney cancer	1.66e-05	0.000566	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—ALAD—kidney cancer	1.64e-05	0.00056	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—PPAT—kidney cancer	1.61e-05	0.00055	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—GLIPR1—kidney cancer	1.61e-05	0.00055	CbGpPWpGaD
Candesartan—UGT1A3—Metabolism—GSTM1—kidney cancer	1.61e-05	0.000549	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—APRT—kidney cancer	1.61e-05	0.000547	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—FH—kidney cancer	1.61e-05	0.000547	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—ST3GAL2—kidney cancer	1.6e-05	0.000546	CbGpPWpGaD
Candesartan—ABCB1—Integrated Pancreatic Cancer Pathway—RAF1—kidney cancer	1.6e-05	0.000546	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism of lipids and lipoproteins—SCARB1—kidney cancer	1.59e-05	0.000543	CbGpPWpGaD
Candesartan—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—kidney cancer	1.58e-05	0.00054	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism of lipids and lipoproteins—PTGS1—kidney cancer	1.58e-05	0.000537	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—ALDH1A1—kidney cancer	1.57e-05	0.000534	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—ITPR2—kidney cancer	1.56e-05	0.000533	CbGpPWpGaD
Candesartan—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—kidney cancer	1.55e-05	0.000528	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—IGF2—kidney cancer	1.54e-05	0.000525	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—CDKN2B—kidney cancer	1.54e-05	0.000523	CbGpPWpGaD
Candesartan—UGT1A3—Metabolism—CYP1A1—kidney cancer	1.53e-05	0.000521	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—GPC3—kidney cancer	1.51e-05	0.000514	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—PGK1—kidney cancer	1.5e-05	0.000512	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—SLC5A3—kidney cancer	1.5e-05	0.000512	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—FH—kidney cancer	1.5e-05	0.000511	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—APRT—kidney cancer	1.5e-05	0.000511	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—IGF1R—kidney cancer	1.49e-05	0.000508	CbGpPWpGaD
Candesartan—ABCB1—Transmembrane transport of small molecules—SLC5A5—kidney cancer	1.47e-05	0.000502	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—LDHB—kidney cancer	1.47e-05	0.000502	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—CA2—kidney cancer	1.47e-05	0.0005	CbGpPWpGaD
Candesartan—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—kidney cancer	1.47e-05	0.0005	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	1.47e-05	0.000499	CbGpPWpGaD
Candesartan—PTGS1—Metabolism of lipids and lipoproteins—POMC—kidney cancer	1.44e-05	0.000491	CbGpPWpGaD
Candesartan—AGTR1—Signaling by GPCR—RAF1—kidney cancer	1.44e-05	0.000489	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—ALAD—kidney cancer	1.43e-05	0.000488	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—GSTT1—kidney cancer	1.43e-05	0.000486	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—ACHE—kidney cancer	1.43e-05	0.000486	CbGpPWpGaD
Candesartan—ABCB1—Transmembrane transport of small molecules—SLC2A1—kidney cancer	1.42e-05	0.000485	CbGpPWpGaD
Candesartan—AGTR1—GPCR downstream signaling—IL2—kidney cancer	1.42e-05	0.000483	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—GPC3—kidney cancer	1.41e-05	0.00048	CbGpPWpGaD
Candesartan—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—kidney cancer	1.4e-05	0.000477	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—ST3GAL2—kidney cancer	1.4e-05	0.000476	CbGpPWpGaD
Candesartan—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—kidney cancer	1.4e-05	0.000476	CbGpPWpGaD
Candesartan—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—kidney cancer	1.39e-05	0.000472	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—CA2—kidney cancer	1.37e-05	0.000467	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—ALDH1A1—kidney cancer	1.37e-05	0.000465	CbGpPWpGaD
Candesartan—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—kidney cancer	1.35e-05	0.00046	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—SCARB1—kidney cancer	1.35e-05	0.00046	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—ALAD—kidney cancer	1.34e-05	0.000456	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—PSMD7—kidney cancer	1.31e-05	0.000446	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—SLC5A3—kidney cancer	1.31e-05	0.000446	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—PGK1—kidney cancer	1.31e-05	0.000446	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—ST3GAL2—kidney cancer	1.31e-05	0.000445	CbGpPWpGaD
Candesartan—AGTR1—Signaling by GPCR—IL2—kidney cancer	1.29e-05	0.000439	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—LDHB—kidney cancer	1.28e-05	0.000437	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—CA9—kidney cancer	1.28e-05	0.000435	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—ALDH1A1—kidney cancer	1.28e-05	0.000435	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	1.25e-05	0.000425	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—BCHE—kidney cancer	1.24e-05	0.000423	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—HIF1A—kidney cancer	1.23e-05	0.000418	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—SLC5A5—kidney cancer	1.23e-05	0.000418	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—TSC2—kidney cancer	1.22e-05	0.000417	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—PGK1—kidney cancer	1.22e-05	0.000417	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—SLC5A3—kidney cancer	1.22e-05	0.000417	CbGpPWpGaD
Candesartan—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—kidney cancer	1.22e-05	0.000416	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—LDHB—kidney cancer	1.2e-05	0.000409	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—SLC2A1—kidney cancer	1.18e-05	0.000404	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—KDR—kidney cancer	1.17e-05	0.0004	CbGpPWpGaD
Candesartan—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—kidney cancer	1.15e-05	0.000393	CbGpPWpGaD
Candesartan—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	1.15e-05	0.000392	CbGpPWpGaD
Candesartan—UGT1A3—Metabolism—POMC—kidney cancer	1.14e-05	0.000388	CbGpPWpGaD
Candesartan—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—kidney cancer	1.12e-05	0.000383	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—CA9—kidney cancer	1.11e-05	0.000379	CbGpPWpGaD
Candesartan—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—kidney cancer	1.1e-05	0.000374	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—CRABP1—kidney cancer	1.09e-05	0.00037	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—KIT—kidney cancer	1.08e-05	0.000368	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—APC—kidney cancer	1.08e-05	0.000368	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—CA9—kidney cancer	1.04e-05	0.000354	CbGpPWpGaD
Candesartan—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—kidney cancer	1.04e-05	0.000353	CbGpPWpGaD
Candesartan—AGTR1—Signaling by GPCR—MAPK3—kidney cancer	1.04e-05	0.000353	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—POMC—kidney cancer	1.03e-05	0.000351	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	1.02e-05	0.000346	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—BRAF—kidney cancer	1.02e-05	0.000346	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—ITPR2—kidney cancer	1.01e-05	0.000344	CbGpPWpGaD
Candesartan—PTGS1—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	1e-05	0.000342	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—GSTP1—kidney cancer	9.88e-06	0.000337	CbGpPWpGaD
Candesartan—AGTR1—Signaling by GPCR—MAPK1—kidney cancer	9.85e-06	0.000336	CbGpPWpGaD
Candesartan—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—kidney cancer	9.53e-06	0.000325	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—CRABP1—kidney cancer	9.46e-06	0.000322	CbGpPWpGaD
Candesartan—AGTR1—GPCR downstream signaling—PIK3CA—kidney cancer	9.41e-06	0.000321	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—ABCB1—kidney cancer	9.36e-06	0.000319	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism of lipids and lipoproteins—POMC—kidney cancer	9.31e-06	0.000317	CbGpPWpGaD
Candesartan—AGTR1—Signaling by GPCR—KRAS—kidney cancer	9.31e-06	0.000317	CbGpPWpGaD
Candesartan—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—kidney cancer	9.22e-06	0.000314	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—ACHE—kidney cancer	9.21e-06	0.000314	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—GSTT1—kidney cancer	9.21e-06	0.000314	CbGpPWpGaD
Candesartan—UGT1A3—Metabolism—PTGS2—kidney cancer	9.09e-06	0.00031	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—GSTM1—kidney cancer	9.08e-06	0.000309	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—CRABP1—kidney cancer	8.84e-06	0.000301	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—ITPR2—kidney cancer	8.8e-06	0.0003	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—SCARB1—kidney cancer	8.72e-06	0.000297	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—PTGS1—kidney cancer	8.63e-06	0.000294	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—CYP1A1—kidney cancer	8.61e-06	0.000293	CbGpPWpGaD
Candesartan—AGTR1—Signaling by GPCR—PIK3CA—kidney cancer	8.55e-06	0.000291	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—RAF1—kidney cancer	8.49e-06	0.000289	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—PSMD7—kidney cancer	8.46e-06	0.000288	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—RELA—kidney cancer	8.45e-06	0.000288	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—ERBB2—kidney cancer	8.4e-06	0.000286	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—MTOR—kidney cancer	8.28e-06	0.000282	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—ITPR2—kidney cancer	8.22e-06	0.00028	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—ACHE—kidney cancer	8.02e-06	0.000273	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—GSTT1—kidney cancer	8.02e-06	0.000273	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—BCHE—kidney cancer	8.02e-06	0.000273	CbGpPWpGaD
Candesartan—UGT1A3—Metabolism—PTEN—kidney cancer	7.93e-06	0.00027	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—SLC5A5—kidney cancer	7.92e-06	0.00027	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—CDKN1B—kidney cancer	7.77e-06	0.000265	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—SLC2A1—kidney cancer	7.65e-06	0.000261	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—IL2—kidney cancer	7.61e-06	0.000259	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—SCARB1—kidney cancer	7.6e-06	0.000259	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism of lipids and lipoproteins—POMC—kidney cancer	7.58e-06	0.000258	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—PTGS1—kidney cancer	7.52e-06	0.000256	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—ACHE—kidney cancer	7.5e-06	0.000255	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—GSTT1—kidney cancer	7.5e-06	0.000255	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	7.43e-06	0.000253	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—CCND1—kidney cancer	7.42e-06	0.000253	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—JUN—kidney cancer	7.4e-06	0.000252	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—PSMD7—kidney cancer	7.37e-06	0.000251	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—CTNNB1—kidney cancer	7.34e-06	0.00025	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—PTEN—kidney cancer	7.16e-06	0.000244	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—SCARB1—kidney cancer	7.1e-06	0.000242	CbGpPWpGaD
Candesartan—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	7.07e-06	0.000241	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—PTGS1—kidney cancer	7.02e-06	0.000239	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—BCHE—kidney cancer	6.99e-06	0.000238	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—SLC5A5—kidney cancer	6.9e-06	0.000235	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—PSMD7—kidney cancer	6.89e-06	0.000235	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—SLC2A1—kidney cancer	6.67e-06	0.000227	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—BCHE—kidney cancer	6.53e-06	0.000222	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	6.48e-06	0.000221	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—VEGFA—kidney cancer	6.47e-06	0.00022	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—SLC5A5—kidney cancer	6.45e-06	0.00022	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—POMC—kidney cancer	6.42e-06	0.000219	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—GSTP1—kidney cancer	6.38e-06	0.000217	CbGpPWpGaD
Candesartan—ABCB1—Transmembrane transport of small molecules—RAF1—kidney cancer	6.36e-06	0.000217	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—SLC2A1—kidney cancer	6.23e-06	0.000212	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—MAPK3—kidney cancer	6.12e-06	0.000208	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	6.04e-06	0.000206	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—ABCB1—kidney cancer	6.04e-06	0.000206	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—MYC—kidney cancer	5.95e-06	0.000203	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—GSTM1—kidney cancer	5.87e-06	0.0002	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—MAPK1—kidney cancer	5.82e-06	0.000198	CbGpPWpGaD
Candesartan—UGT1A3—Metabolism—PIK3CA—kidney cancer	5.59e-06	0.000191	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—GSTP1—kidney cancer	5.56e-06	0.000189	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—CYP1A1—kidney cancer	5.56e-06	0.000189	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—KRAS—kidney cancer	5.5e-06	0.000187	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	5.27e-06	0.00018	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—GSTP1—kidney cancer	5.2e-06	0.000177	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—PTGS2—kidney cancer	5.12e-06	0.000174	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—GSTM1—kidney cancer	5.11e-06	0.000174	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—PIK3CA—kidney cancer	5.05e-06	0.000172	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—ABCB1—kidney cancer	4.92e-06	0.000168	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—TP53—kidney cancer	4.89e-06	0.000166	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—CYP1A1—kidney cancer	4.84e-06	0.000165	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—GSTM1—kidney cancer	4.77e-06	0.000163	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	4.57e-06	0.000156	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—CYP1A1—kidney cancer	4.53e-06	0.000154	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—PTEN—kidney cancer	4.47e-06	0.000152	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—POMC—kidney cancer	4.15e-06	0.000141	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	3.72e-06	0.000127	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—POMC—kidney cancer	3.61e-06	0.000123	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—POMC—kidney cancer	3.37e-06	0.000115	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—PTGS2—kidney cancer	3.31e-06	0.000113	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—PIK3CA—kidney cancer	3.15e-06	0.000107	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—PTEN—kidney cancer	2.88e-06	9.83e-05	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—PTGS2—kidney cancer	2.88e-06	9.82e-05	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—PTGS2—kidney cancer	2.69e-06	9.17e-05	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—PTEN—kidney cancer	2.51e-06	8.56e-05	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—PTEN—kidney cancer	2.35e-06	8e-05	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—PIK3CA—kidney cancer	2.03e-06	6.93e-05	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—PIK3CA—kidney cancer	1.77e-06	6.04e-05	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—PIK3CA—kidney cancer	1.66e-06	5.64e-05	CbGpPWpGaD
